According to court documents filed Tuesday, Angelina Jolie allegedly used devious means to try to keep ex-husband Brad Pitt out of a lucrative real estate deal involving a posh estate they co-owned in France.
According to the documents filed in Luxembourg, Angelina is accused of attempting to sell her 50% stake in the $164 million Chateau Miraval in Correns, France, without first giving her ex-husband the option to buy her out.
The 1,000-acre estate held special significance for the couple because it was the site of their secret wedding in 2014, attended by only their six children.
The allegations of petty dealing come as the couple’s attorneys returned to court on Monday in yet another salvo in their long-running custody battle over their children, according to a recent report by SurgeZirc US.
Brad Pitt, 57, and his former wife Angelina Jolie, 46, each held their Miraval shares in separate limited liability companies (LLCs). Miraval is owned by Quimicum, a company in which Brad held a 60% stake through his company Mondo Bongo and Angelina kept a 40% stake through her company Nouvel.
Three years before their divorce process commenced in 2016, the “Mr and Mrs Smith” actor transferred 10% of his estate from Mondo Bongo to Angelina Jolie’s Nouvel which actively made them equal shareholders of the estate.
SurgeZirc FR has also learned that as part of their agreement, the former couple and co-actors who shared several screens together agreed to ask each other for permission to sell their shares if they ever wanted to.
As a result, the suit now claims that Angelina Jolie attempted to sell her shares without giving Brad Pitt first refusal. “He did all the work; she did nothing,” according to a source.
According to the lawsuit, the 10% transfer should be declared null and void because the shares were “sold” for only €1 rather than the “serious” amount required by Luxembourg law. It is now worth more than €140 million (approximately $164 million).
“It is worth mentioning that, for the last four years, Nouvel [Jolie’s company] did not act in the best interest of Quimicum by systematically delaying the approval of the annual accounts and the renewal of the manager,” the suit states.
“We understand that behind this systematic obstruction, the real purpose of Nouvel and its shareholder ‘Jolie’ is to sell its stake in Chateau Miraval SA in a way that would circumvent Mondo Bongo’s right of first refusal as provided in Quimicum’s articles of approval, taking, as a result, a capital gain raised thanks to Mondo Bongo’s investment and to which Nouvel did not contribute,” it added.